These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 2128598)

  • 1. Effect of cisplatin and other biological response modifiers on the activity of lysozyme, plasminogen activator and 5' nucleotidase by murine macrophages in vitro.
    Geetha B; Sodhi A
    Biochem Int; 1990 Dec; 22(6):1103-14. PubMed ID: 2128598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of cisplatin, lipopolysaccharide, muramyl dipeptide and recombinant interferon-gamma on murine macrophages in vitro. I. Macrophage-mediated tumor cell lysis.
    Geetha B; Sodhi A
    Nat Immun Cell Growth Regul; 1989; 8(2):100-7. PubMed ID: 2503714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of cisplatin, lipopolysaccharide, muramyl dipeptide and recombinant interferon-gamma on murine macrophages in vitro. II. Production of H2O2, O2- and interleukin-1.
    Sodhi A; Geetha B
    Nat Immun Cell Growth Regul; 1989; 8(2):108-16. PubMed ID: 2548090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on the release of interleukin-1 (IL-1), tumor necrosis factor (TNF) and lysozyme from human non-adherent mononuclear cells (nMNC) in vitro after treatment with cisplatin and other biological response modifiers.
    Sodhi A; Pai K
    Neoplasma; 1992; 39(4):211-7. PubMed ID: 1436230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of cisplatin, rIFN-Y, LPS and MDP on release of H2O2, O2- and lysozyme from human monocytes in vitro.
    Pai K; Sodhi A
    Indian J Exp Biol; 1991 Oct; 29(10):910-5. PubMed ID: 1667647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of cisplatin on release of lysozyme, plasminogen activator, leucine aminopeptidase and beta-hexosaminidase by murine peritoneal macrophages in vitro.
    Gupta P; Sodhi A
    Indian J Exp Biol; 1988 Sep; 26(9):679-84. PubMed ID: 2977380
    [No Abstract]   [Full Text] [Related]  

  • 7. Production of tumor necrosis factor by rIFN-gamma-primed C3H/HeJ (Lpsd) macrophages requires the presence of lipid A-associated proteins.
    Hogan MM; Vogel SN
    J Immunol; 1988 Dec; 141(12):4196-202. PubMed ID: 3143760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on chemiluminescence and protein kinase-C activity of cisplatin treated mouse peritoneal exudate cells.
    Geetha B; Sodhi A; Singh SM
    Immunopharmacol Immunotoxicol; 1991; 13(1-2):1-10. PubMed ID: 1770212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The activation of tumoricidal properties in macrophages of endotoxin responder and nonresponder mice by liposome-encapsulated immunomodulators.
    Fogler WE; Talmadge JE; Fidler IJ
    J Reticuloendothel Soc; 1983 Mar; 33(3):165-74. PubMed ID: 6834360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic activation by recombinant mouse interferon-gamma and muramyl dipeptide of tumoricidal properties in mouse macrophages.
    Saiki I; Fidler IJ
    J Immunol; 1985 Jul; 135(1):684-8. PubMed ID: 3923117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Augmentation by priming with interferon-gamma of the binding of a muramyl dipeptide derivative to macrophages resulting in synergistic macrophage activation.
    Nagao S; Sato K; Osada Y
    Jpn J Cancer Res; 1987 Jan; 78(1):80-6. PubMed ID: 3102442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipid A-associated proteins provide an alternate "second signal" in the activation of recombinant interferon-gamma-primed, C3H/HeJ macrophages to a fully tumoricidal state.
    Hogan MM; Vogel SN
    J Immunol; 1987 Dec; 139(11):3697-702. PubMed ID: 3119714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antimetastatic effect of a liposome-entrapped synthetic analog of muramyl dipeptide].
    Umanskiĭ VIu; Stefanov AV; Los' GV; Andronova TM; Balitskiĭ KP
    Dokl Akad Nauk SSSR; 1986; 286(2):474-6. PubMed ID: 3004870
    [No Abstract]   [Full Text] [Related]  

  • 14. The response of isolated rabbit hepatic macrophages (H-M macrophage) to lipopolysaccharide (LPS).
    Maier RV; Ulevitch RJ
    Circ Shock; 1981; 8(2):165-81. PubMed ID: 7194747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down-regulation of Fc receptor expression in guinea pig peritoneal exudate macrophages by muramyl dipeptide or lipopolysaccharide.
    Yagawa K; Kaku M; Ichinose Y; Nagao S; Tanaka A; Aida Y; Tomoda A
    J Immunol; 1985 Jun; 134(6):3705-11. PubMed ID: 2985692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of macrophage tumoricidal activity by glucocorticoids.
    Hogan MM; Vogel SN
    J Immunol; 1988 Jan; 140(2):513-9. PubMed ID: 3121748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of lipopolysaccharide-induced cytokine gene expression in mouse bone marrow-derived macrophages by muramyl dipeptide.
    Le Contel C; Temime N; Charron DJ; Parant MA
    J Immunol; 1993 May; 150(10):4541-9. PubMed ID: 8482846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic generation of tumoricidal macrophages by muroctasin and interferon-gamma.
    Nagao S; Sato K; Osada Y
    Arzneimittelforschung; 1988 Jul; 38(7A):999-1002. PubMed ID: 3142490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The effect of muramyl dipeptide analog, GMPD, incorporated into liposomes of various composition on the functional activity of macrophages].
    Stefanov AV; Bondar' OP; Umanskiĭ VIu; Lishko VK; Baletskiĭ KP
    Ukr Biokhim Zh (1978); 1989; 61(6):63-9. PubMed ID: 2561033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative effect of muramyl dipeptide in vivo and in vitro on the tumoricidal activity of rat peritoneal macrophages.
    Reisser D; Jeannin JF; Lagadec P; Martin F
    J Biol Response Mod; 1985 Oct; 4(5):460-3. PubMed ID: 4078593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.